The 2 analysts offering 12-month price forecasts for Aridis Pharmaceuticals Inc have a median target of 12.00, with a high estimate of 19.00 and a low estimate of 5.00. The median estimate represents a +1,000.92% increase from the last price of 1.09.
The current consensus among 2 polled investment analysts is to Buy stock in Aridis Pharmaceuticals Inc. This rating has held steady since May, when it was unchanged from a Buy rating.Move your mouse over past months for detail
Earnings and Sales Forecasts
Earnings per Share -$0.06
Reporting Date Aug 16
Earnings per Share
Move your mouse over a quarter or year to see how estimates have changed over time.